Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) unit Shanghai Fosun Health Technology will inject 30 million yuan into Shanghai Zhuoerhui Integrated Outpatient.
The capital contribution will mainly be to support the target company's daily operations and the construction of its disciplines, branding, and marketing system.
Following completion, Fosun Health's shareholding in the target will rise to 67.1872% from 57.5363%, a Thursday filing with the Hong Kong bourse said.
Shanghai Zhuoerhui Integrated Outpatient mainly provides medical services such as physical examination and general and specialist outpatient clinics.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.